The article on management of insomnia in primary care (Aust Prescr 2021;44:124-8) has been corrected. View corrected article.
In the drug management paragraph on melatonin, the treatment duration should have been over a ‘three-week period’ rather than a 13-week period: “Melatonin (2 mg extended-release formulation) is effective in treating insomnia in adults over the age of 55 over a three-week period.”
Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer. This website uses cookies. Read our privacy policy.